Abcam Plc  

(Public, LON:ABC)   Watch this stock  
Find more results for Jane Roe
-1.91 (-0.41%)
Mar 3 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 465.25 - 475.00
52 week 346.00 - 495.00
Open 468.25
Vol / Avg. 104,895.00/501,845.00
Mkt cap 940.97M*
P/E 27.58
Div/yield 5.62/1.65*
EPS 0.17*
Shares 200.87M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '14) 2014
Net profit margin 26.58% 26.61%
Operating margin 33.62% 33.85%
EBITD margin - 36.69%
Return on average assets 17.45% 16.75%
Return on average equity 19.91% 19.39%
Employees 734 -
CDP Score - -


330 Cambridge Science Park
United Kingdom - Map
+44-1223-696000 (Phone)
+44-1223-771600 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Abcam plc is a producer and distributor of research-grade antibodies and associated protein research products, which are essential tools for life scientists, enabling them to analyse components of living cells at the molecular level. The Company develops and manufactures its own products, as well as externally sourcing products. The Company�s product includes Primary antibodies, including RabMAbs (rabbit monoclonal antibodies), Secondary antibodies, Functional assays, ELISA and other kits, Biochemicals, Proteins and peptides and Lysates. The Company�s subsidiaries include Abcam Inc, Abcam KK, Abcam (Hong Kong) Limited, Abcam Employee Share Benefit Trust Limited, Abcam Epitomics Holdings, Inc, Abcam US Group Holdings Inc, Abcam LLC and Abcam (US) Limited.

Officers and directors

Alan Thomas Hirzel Chief Executive Officer, Executive Director
Jeff Michel Iliffe Chief Financial Officer, Company Secretary, Executive Director
Jim Warwick Chief Operating Officer, Executive Director
Sean Hickey Chief Information Officer
Mark Bushfield Ph.D Scientific Director
Jane Cooke People and Organisational Development Director
Philippe Cotrel Ph.D. Commercial Director
Danielle Miller Ph.D. Operations Director
Ed Ralph Ph.D. Head of Digital and Brand Marketing
Matthew Roe Head of Reagents